Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Hepatitis C Virus”

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02950870
What this trial is testing

Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.

Who this might be right for
Chronic Hepatitis, C Virus
University of Modena and Reggio Emilia 75
Testing effectiveness (Phase 2)Study completedNCT02765490
What this trial is testing

Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Research & Development, LLC 365
Large-scale testing (Phase 3)Study completedNCT01399619
What this trial is testing

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 310
Not applicableStudy completedNCT01641094
What this trial is testing

Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 20
Early research (Phase 1)Study completedNCT01081158
What this trial is testing

Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 41
Not applicableEnded earlyNCT01250743
What this trial is testing

A Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis C

Who this might be right for
Hepatitis C
Health Innovations, Frontier Research Institute 10
Testing effectiveness (Phase 2)Study completedNCT00882908
What this trial is testing

TMC435 in Combination With Pegylated Interferon Alp\Fa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment

Who this might be right for
Hepatitis C
Tibotec Pharmaceuticals, Ireland 386
Large-scale testing (Phase 3)Study completedNCT00758043
What this trial is testing

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 540
Post-approval studies (Phase 4)Ended earlyNCT02940691
What this trial is testing

Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs

Who this might be right for
Hepatitis C
Kirby Institute 32
Not applicableWithdrawnNCT00571714
What this trial is testing

Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients

Who this might be right for
Chronic Hepatitis C
University of Nebraska
Post-approval studies (Phase 4)Ended earlyNCT00255008
What this trial is testing

Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 121
Testing effectiveness (Phase 2)UnknownNCT00332176
What this trial is testing

Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
BioWest Therapeutics Inc 50
Testing effectiveness (Phase 2)UnknownNCT01272310
What this trial is testing

Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.

Who this might be right for
Chronic Hepatitis C
Sheba Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT00157534
What this trial is testing

Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
BioWest Therapeutics Inc 43
Post-approval studies (Phase 4)Ended earlyNCT01467492
What this trial is testing

Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 121
Testing effectiveness (Phase 2)Study completedNCT01225380
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Infection
Gilead Sciences 324
Post-approval studies (Phase 4)Study completedNCT00910975
What this trial is testing

Individualized Duration of Peg-interferon/Ribavirin Treatment of Hepatitis C

Who this might be right for
Chronic Hepatitis C, Genotype 1
Göteborg University 100
Testing effectiveness (Phase 2)Study completedNCT00980330
What this trial is testing

A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment

Who this might be right for
Hepatitis C
Tibotec Pharmaceuticals, Ireland 463
Large-scale testing (Phase 3)Study completedNCT02399345
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults

Who this might be right for
Chronic Hepatitis C Virus (HCV Infection Genotype 1)
AbbVie 10
Testing effectiveness (Phase 2)Study completedNCT00217139
What this trial is testing

Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
BioWest Therapeutics Inc 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation